Risk minimization measures
Risk minimization measures
| Scientific Name | Brand name | Approval Date | Last Update | Details |
|---|---|---|---|---|
| vandetanib | Caprelsa | View | ||
| Botulinum Toxin Type A | Nabota | View | ||
| Human Fibrinogen | Fibryga | View | ||
| recombinant, adjuvanted | AREXVY | View | ||
| bivalent, recombinant | ABRYSVO | View | ||
| Methylphenidate | CONCENTIA | View | ||
| Methylphenidate | QUILLIVANT XR | View | ||
| Methylphenidate | CONCERTA | View | ||
| Lisdexamfetamine Dimesilate | VYVANSE | View | ||
| Methylphenidate | RITALIN | View |